Danaher Corporation DHRC.VI Stock
Danaher Corporation Price Chart
Danaher Corporation DHRC.VI Financial and Trading Overview
Danaher Corporation stock price | 226.3 EUR |
Previous Close | 220.3 EUR |
Open | 220.3 EUR |
Bid | 221.4 EUR x N/A |
Ask | 223.7 EUR x N/A |
Day's Range | 220.3 - 220.3 EUR |
52 Week Range | 206.8 - 297.5 EUR |
Volume | 0 EUR |
Avg. Volume | 2 EUR |
Market Cap | 162.56B EUR |
Beta (5Y Monthly) | 0.803169 |
PE Ratio (TTM) | 25.616278 |
EPS (TTM) | 5.25 EUR |
Forward Dividend & Yield | 0.98 (0.44%) |
Ex-Dividend Date | June 29, 2023 |
1y Target Est | N/A |
DHRC.VI Valuation Measures
Enterprise Value | 178.38B EUR |
Trailing P/E | 25.616278 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.252315 |
Price/Book (mrq) | 3.2250981 |
Enterprise Value/Revenue | 5.763 |
Enterprise Value/EBITDA | 16.866 |
Trading Information
Danaher Corporation Stock Price History
Beta (5Y Monthly) | 0.803169 |
52-Week Change | -5.22% |
S&P500 52-Week Change | 20.43% |
52 Week High | 297.5 EUR |
52 Week Low | 206.8 EUR |
50-Day Moving Average | 218.78 EUR |
200-Day Moving Average | 243.3 EUR |
DHRC.VI Share Statistics
Avg. Volume (3 month) | 2 EUR |
Avg. Daily Volume (10-Days) | 1 EUR |
Shares Outstanding | 737.9M |
Float | 653.79M |
Short Ratio | N/A |
% Held by Insiders | 10.77% |
% Held by Institutions | 79.69% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.02 |
Trailing Annual Dividend Yield | 0.46% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.109799996 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 22.40% |
Operating Margin (ttm) | 27.01% |
Gross Margin | 60.14% |
EBITDA Margin | 34.17% |
Management Effectiveness
Return on Assets (ttm) | 6.20% |
Return on Equity (ttm) | 14.17% |
Income Statement
Revenue (ttm) | 30.95B EUR |
Revenue Per Share (ttm) | 42.49 EUR |
Quarterly Revenue Growth (yoy) | -6.80% |
Gross Profit (ttm) | 18.95B EUR |
EBITDA | 10.58B EUR |
Net Income Avi to Common (ttm) | 6.85B EUR |
Diluted EPS (ttm) | 8.6 |
Quarterly Earnings Growth (yoy) | -15.90% |
Balance Sheet
Total Cash (mrq) | 7.38B EUR |
Total Cash Per Share (mrq) | 10 EUR |
Total Debt (mrq) | 20.93B EUR |
Total Debt/Equity (mrq) | 40.66 EUR |
Current Ratio (mrq) | 1.894 |
Book Value Per Share (mrq) | 68.308 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.5B EUR |
Levered Free Cash Flow (ttm) | 5.88B EUR |
Profile of Danaher Corporation
Country | Austria |
State | DC |
City | Washington |
Address | 2200 Pennsylvania Avenue, North West |
ZIP | 20037-1701 |
Phone | 202 828 0850 |
Website | https://www.danaher.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 79000 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.
Q&A For Danaher Corporation Stock
What is a current DHRC.VI stock price?
Danaher Corporation DHRC.VI stock price today per share is 226.3 EUR.
How to purchase Danaher Corporation stock?
You can buy DHRC.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Danaher Corporation?
The stock symbol or ticker of Danaher Corporation is DHRC.VI.
Which industry does the Danaher Corporation company belong to?
The Danaher Corporation industry is Diagnostics & Research.
How many shares does Danaher Corporation have in circulation?
The max supply of Danaher Corporation shares is 740.54M.
What is Danaher Corporation Price to Earnings Ratio (PE Ratio)?
Danaher Corporation PE Ratio is 43.10476300 now.
What was Danaher Corporation earnings per share over the trailing 12 months (TTM)?
Danaher Corporation EPS is 5.25 EUR over the trailing 12 months.
Which sector does the Danaher Corporation company belong to?
The Danaher Corporation sector is Healthcare.